Suppr超能文献

清醒俯卧位通气治疗低氧性呼吸衰竭:过去、COVID-19 及展望。

Awake prone positioning for hypoxaemic respiratory failure: past, COVID-19 and perspectives.

机构信息

Service des Maladies Respiratoires, CH Aix-en-Provence, Aix-en-Provence, France

Service des Maladies Respiratoires, CH Aix-en-Provence, Aix-en-Provence, France.

出版信息

Eur Respir Rev. 2021 May 5;30(160). doi: 10.1183/16000617.0022-2021. Print 2021 Jun 30.

Abstract

Prone positioning reduces mortality in the management of intubated patients with moderate-to-severe acute respiratory distress syndrome. It allows improvement in oxygenation by improving ventilation/perfusion ratio mismatching.Because of its positive physiological effects, prone positioning has also been tested in non-intubated, spontaneously breathing patients, or "awake" prone positioning. This review provides an update on awake prone positioning for hypoxaemic respiratory failure, in both coronavirus disease 2019 (COVID-19) and non-COVID-19 patients. In non-COVID-19 acute respiratory failure, studies are limited to a few small nonrandomised studies and involved patients with different diseases. However, results have been appealing with regard to oxygenation improvement, especially when combined with noninvasive ventilation or high-flow nasal cannula.The recent COVID-19 pandemic has led to a major increase in hospitalisations for acute respiratory failure. Awake prone positioning has been used with the aim to prevent intensive care unit admission and mechanical ventilation. Prone positioning in conscious, non-intubated COVID-19 patients is used in emergency departments, medical wards and intensive care units.Several trials reported an improvement in oxygenation and respiratory rate during prone positioning, but impacts on clinical outcomes, particularly on intubation rates and survival, remain unclear. Tolerance of prolonged prone positioning is an issue. Larger controlled, randomised studies are underway to provide results concerning clinical benefit and define optimised prone positioning regimens.

摘要

俯卧位通气可降低中重度急性呼吸窘迫综合征患者气管插管患者的死亡率。它通过改善通气/血流比例不匹配来提高氧合。由于其积极的生理效应,俯卧位通气也已在非插管、自主呼吸患者或“清醒”俯卧位患者中进行了测试。这篇综述介绍了 COVID-19 和非 COVID-19 患者中,清醒俯卧位通气治疗低氧性呼吸衰竭的最新进展。在非 COVID-19 急性呼吸衰竭中,研究仅限于少数小型非随机研究,且涉及不同疾病的患者。然而,在改善氧合方面的结果令人关注,尤其是与无创通气或高流量鼻导管联合使用时。最近的 COVID-19 大流行导致急性呼吸衰竭的住院人数大幅增加。俯卧位通气被用于预防入住重症监护病房和机械通气。清醒、非插管的 COVID-19 患者在急诊科、医疗病房和重症监护病房中使用俯卧位通气。几项试验报告称,俯卧位通气时氧合和呼吸频率有所改善,但对临床结局(特别是插管率和生存率)的影响仍不清楚。长时间俯卧位通气的耐受性是一个问题。正在进行更大规模的对照、随机研究,以提供有关临床获益的结果,并确定最佳俯卧位通气方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a149/9488782/5290ac763152/ERR-0022-2021.01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验